Schneider Electric Previews Asset Management Strategy for Puerto Rican Pharmaceutical Customers

More than 67 of Puerto Rico's pharmaceutical manufacturing leaders gathered in San Juan recently to preview Schneider Electric's "Electrical Asset Management" offering. The four-day event focused on maximizing return on investment (ROI) of capital equipment by minimizing equipment lifecycle costs. Representatives from Fluor Daniel, Eli Lilly, Pharmacia, Pfizer, Wyeth, Merck, Bristol Myers Squibb,

More than 67 of Puerto Rico's pharmaceutical manufacturing leaders gathered in San Juan recently to preview Schneider Electric's "Electrical Asset Management" offering. The four-day event focused on maximizing return on investment (ROI) of capital equipment by minimizing equipment lifecycle costs.

Representatives from Fluor Daniel, Eli Lilly, Pharmacia, Pfizer, Wyeth, Merck, Bristol Myers Squibb, Abbott, Searle, and Astra Zeneca attended seminars, spoke with product managers, and learned about the company's first wave of products and services.

According to Mark Liston, global sales director, pharmaceutical accounts, the company's Electrical Asset Management system focuses on the five stages in an equipment lifecycle: acquisition, deployment, operation, maintenance, and disposal.

"The response we received in Puerto Rico was exceptional and validated our view of Electrical Asset Management that customers need more than databasing software and leasing options on their purchases to manage the lifetime costs of their equipment,” said Liston

TAGS: content
Hide comments

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish